Contact
Login
Forgot password?
Prism_2_LOGO_png.png
About PRISM 2
Facts & Figures
Expected Impact
Management
Partners
Advisory Boards
For Scientists
Background
Objectives
Work Packages
Publications
Masterclasses
For Patients & Relatives
Clinical Study
Public Deliverables
Useful Links
Downloads
News & Events
Project News & Events
Project Meetings
Press Coverage
Scientific Conferences

PRISM    

PRISM findings
Lay Summary (English)
Lay Summary (Dutch)
Lay Summary (Spanish)
Lay Summary (German)
Lay Summary (French)
Contact
Login
  • Home
  • /
  • Prism1Publications

Category: Prism1Publications

The human neuropsychiatric risk gene Drd2 is necessary for social functioning across evolutionary distant species

Ike et al. (2023): The human neuropsychiatric risk gene Drd2 is necessary for social functioning across evolutionary distant species. Molecular Psychiatry.



Digital behavioural signatures reveal trans-diagnostic clusters of Schizophrenia and Alzheimer’s disease patients

Kas et al. (2024): Digital behavioural signatures reveal trans-diagnostic clusters of Schizophrenia and Alzheimer’s disease patients. European Neuropsychopharmacology.



Models and methods: a perspective of the impact of six IMI translational data-centric initiatives for Alzheimer’s disease and other neuropsychiatric disorders

North et al. (2023): Models and methods: a perspective of the impact of six IMI translational data-centric initiatives for Alzheimer’s disease and other neuropsychiatric disorders. Frontiers in Neurology.



Cross-disorder and disorder-specific deficits in social functioning among schizophrenia and alzheimer’s disease patients

Saris et al. (2022): Cross-disorder and disorder-specific deficits in social functioning among schizophrenia and alzheimer’s disease patients. PLos One, in press.



Social dysfunction is transdiagnostically associated with default mode network dysconnectivity in schizophrenia and Alzheimer’s disease

Saris et al. (2021): Social dysfunction is transdiagnostically associated with default mode network dysconnectivity in schizophrenia and Alzheimer’s disease. World J Biol Psychiatry.



Relationships between social withdrawal and facial emotion recognition in neuropsychiatric disorders

De la Torre-Luque et al. (2022): Relationships between social withdrawal and facial emotion recognition in neuropsychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry.



Social withdrawal as a trans-diagnostic predictor of short-term remission: a meta-analysis of five clinical cohorts

Oliva et al. (2022): Social withdrawal as a trans-diagnostic predictor of short-term remission: a meta-analysis of five clinical cohorts. Int Clin Psychopharmacol.



Social behavior assessment in cognitively impaired older adults using a passive and remote smartphone application

Muurling et al. (2021): Social behavior assessment in cognitively impaired older adults using a passive and remote smartphone application. Alzheimers and Dementia.



Effect of disease related biases on the subjective assessment of social functioning in Alzheimer’s disease and schizophrenia patients

Jongs et al. (2022): Effect of disease related biases on the subjective assessment of social functioning in Alzheimer’s disease and schizophrenia patients. Journal of Psychiatric Research.



Mismatch negativity as EEG biomarker supporting CNS drug development: a transnosographic and translational study

Loiodice et al. (2021): Mismatch negativity as EEG biomarker supporting CNS drug development: a transnosographic and translational study. Translational Psychiatry.



Posts navigation

Page 1 Page 2 … Page 6 Next page

Resources

  • Clinical Study
  • Work Packages
  • Publications
  • Partners
  • Useful Links
  • Downloads
  • Newsletter
  • Contact
Follow us on social media:
LinkedIn Twitter

The PRISM 2 project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 101034377. The JU receives support from the European Union’s Horizon 2020 research and innovation programme, EFPIA, and Cohen Veterans Bioscience (CVB). The website reflects only the authors' views and IMI JU, EFPIA, CVB, and the European Commission are not responsible for any use that may be made of the information it contains.

Login Contact Privacy Policy Legal Disclaimer
© PRISM 2 consortium 2025
Manage Cookie Consent
We use cookies to improve your experience. Until you consent, only those cookies necessary to maintain the website's basic functionality are active. Website features, security and statistics are best if you activate "All cookies" (incl. Twitter, YouTube, Google reCAPTCHA and Google Analytics). You can revoke your choice at any time. Just clear your browser cache and update your settings. Please also view our Privacy Policy.

 
Functional cookies only Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistical cookies
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
All cookies
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
Your cookie preferences
{title} {title} {title}